Blood Transfusion Diagnostics Market Study by Price, Revenue and Gross Margin Analysis by 2028

San Francisco, California , USA, Dec 02, 2022 — /EPR Network/ —

Blood Transfusion Diagnostics Industry Overview

The global Blood Transfusion Diagnostics Market size is expected to reach USD 5.8 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.6% from 2021 to 2027. The growing prevalence of chronic diseases coupled with increasing demand for disease screening is significantly driving the market growth.

Some of the chronic infectious diseases such as hepatitis B, hepatitis C, HIV, and syphilis create the need for accurate donor screening, further driving the market growth. There is an increasing risk of Transfusion-transmitted Infections (TTIs) that has led to high demand for donor screening. In order to prevent patients from unsuitable blood and blood products and combat TTIs, the need for donor screening is increasing.

Transfusion is commonly used in cases of trauma, road accidents, surgeries, childbirth, and gastrointestinal bleeding in order to replace major blood losses. A victim affected by a car accident may require up to 30 units of blood. The rising number of surgeries such as coronary artery bypass grafting, elective repair of aortic aneurysm, and primary total hip replacement has led to high demand for blood transfusions, thus, driving the need for blood transfusion diagnostic tools. In order to combat such factors, Dublin Fire Brigade and THE GARDAÍ, COAST Guard, Defence Forces partnered with the Irish Blood Transfusion Service (IBTS) with an aim to promote the significance of giving blood.

Blood Transfusion Diagnostics Market Segmentation

Grand View Research has segmented the global blood transfusion diagnostics market on the basis of product, application, end use, and region:

Based on the Product Type Insights, the market is segmented into Reagents & Kits, Instruments, and Others

  • In 2020, the reagents and kits segment dominated the market for blood transfusion diagnostics and accounted for the largest revenue share of 65.8%.
  • Easy availability of products and repetitive purchase of these products required to screen both donor and recipient samples have majorly driven the segment growth.

Based on the Application Insights, the market is segmented into Blood Grouping and Disease Screening

  • The disease screening segment dominated the market for blood transfusion diagnostics and accounted for the largest revenue share of 60.0% in 2020.
  • The blood grouping segment is expected to hold a significant revenue share during the study period.

Based on the End-use Insights, the market is segmented into Hospitals, Blood Banks, Diagnostic Laboratories, and Others

  • The blood banks segment dominated the market for blood transfusion diagnostics and accounted for the largest revenue share of 38.9% in 2020.
  • This is due to a large number of disease screening and blood typing services performed before transfusion therapy.

Blood Transfusion Diagnostics Regional Outlook

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

The market is gaining considerable attention from several companies and regulatory authorities. Companies in this market are continuously undertaking various strategic initiatives to accelerate the development and manufacture of diagnostic tests for blood in turn gaining a competitive edge over others.

Some prominent players in the global Blood Transfusion Diagnostics market include:

  • Immucor, Inc.
  • Abbott
  • Ortho Clinical Diagnostics
  • Bio-Rad Laboratories
  • Quotient Limited
  • Hoffmann-La Roche AG
  • DiaSorin S.P.A.
  • BAG Healthcare GmbH
  • Danaher
  • BIOKIT (Werfen)

Order a free sample PDF of the Blood Transfusion Diagnostics Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.


Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519



Follow Us: LinkedIn | Twitter


Matched content

Editor’s pick

Express Press Release Distribution